Phenotypes of chronic fatigue syndrome in children and young people.
May, Margaret, Emond, Alan, Crawley, Esther · Archives of disease in childhood · 2010 · DOI
Quick Summary
Researchers studied 333 children and young people with ME/CFS to see if the illness presents differently in different people. They found three main patterns: one involving muscle and joint pain, another involving migraine-like symptoms with sensitivity to light and sound, and a third involving sore throat and swollen lymph nodes. These different patterns were linked to varying levels of severity, suggesting that ME/CFS affects children in different ways.
Why It Matters
This study demonstrates that ME/CFS in children is not a single uniform condition but comprises distinct symptom clusters that differ in severity and associated features. Recognizing these phenotypes could help clinicians tailor assessment and treatment strategies, and may ultimately guide targeted research into different biological mechanisms underlying ME/CFS.
Observed Findings
Three distinct symptom phenotypes were identified through factor analysis: musculoskeletal (muscle/joint pain, touch hypersensitivity), migraine (light/noise sensitivity, headaches, nausea, dizziness), and sore throat (pharyngitis, lymphadenopathy).
The musculoskeletal phenotype was associated with worse fatigue (coefficient 0.47, p<0.001) and impaired physical function (coefficient -0.52, p=0.001).
The migraine phenotype showed strongest association with reduced physical function and pain.
No phenotypes were associated with age, illness duration, or depression symptoms.
The migraine phenotype was significantly associated with anxiety (coefficient 0.40, p=0.02).
Inferred Conclusions
ME/CFS in children demonstrates heterogeneity with identifiable clinical phenotypes present at initial assessment.
Phenotypes are associated with differential severity markers, with musculoskeletal and migraine presentations linked to greater functional impairment and pain.
These phenotypes are unlikely to reflect disease stage (age or illness duration) or primary psychiatric etiology (depression), though anxiety may co-occur with the migraine phenotype.
Remaining Questions
Do these phenotypes remain stable over the course of illness, or do patients shift between phenotypes over time?
What This Study Does Not Prove
This cross-sectional study cannot establish causation or determine whether these phenotypes represent truly distinct biological subtypes versus symptom clustering in a single disease. It does not prove that phenotypes remain stable over time, respond differently to treatment, or have different underlying mechanisms. The study also cannot establish why certain phenotypes associate with anxiety or whether these associations reflect causation.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
Do the three phenotypes respond differently to specific treatments or interventions?
What biological mechanisms underlie each phenotype, and are there distinct pathophysiological pathways?
Does the association between the migraine phenotype and anxiety reflect a causal relationship, shared etiology, or secondary anxiety to symptom burden?